Stay updated on LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T14:59:21.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:15:28.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the full study record content with a minimal error page; core elements such as study details and related documents are no longer accessible.
    Difference
    21%
    Check dated 2026-09-20T10:36:43.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6, indicating a minor page revision with no substantive changes to study details.
    Difference
    0.1%
    Check dated 2026-08-30T00:38:41.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page revision label was updated from Revision: v3.6.4 to Revision: v3.6.5. This signals a minor update to the page content or underlying platform, rather than a major user-facing change.
    Difference
    0.1%
    Check dated 2026-08-08T23:34:17.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, reflecting a new page version without changing substantive content.
    Difference
    0.1%
    Check dated 2026-07-25T17:05:25.000Z thumbnail image

Stay in the know with updates to LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.